CLINICAL_TRIALS trial_result · 2021-01-14

Clinical Trial Update: cAd3-Marburg Vaccine in Healthy Adults [Phase 1]

Summary

Phase 1 trial of cAd3-Marburg vaccine in healthy adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Marburg Virus Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-01-14